JPWO2021010712A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021010712A5 JPWO2021010712A5 JP2022503414A JP2022503414A JPWO2021010712A5 JP WO2021010712 A5 JPWO2021010712 A5 JP WO2021010712A5 JP 2022503414 A JP2022503414 A JP 2022503414A JP 2022503414 A JP2022503414 A JP 2022503414A JP WO2021010712 A5 JPWO2021010712 A5 JP WO2021010712A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- variable region
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190085233 | 2019-07-15 | ||
| KR10-2019-0085233 | 2019-07-15 | ||
| PCT/KR2020/009207 WO2021010712A1 (ko) | 2019-07-15 | 2020-07-13 | 항-타우 항체 및 이의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541539A JP2022541539A (ja) | 2022-09-26 |
| JPWO2021010712A5 true JPWO2021010712A5 (es) | 2023-07-24 |
Family
ID=74088428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022503414A Pending JP2022541539A (ja) | 2019-07-15 | 2020-07-13 | 抗タウ抗体およびその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220204601A1 (es) |
| EP (1) | EP4001305A4 (es) |
| JP (1) | JP2022541539A (es) |
| KR (1) | KR102196840B1 (es) |
| CN (1) | CN114430744B (es) |
| AU (1) | AU2020313751A1 (es) |
| BR (1) | BR112022000719A2 (es) |
| CA (1) | CA3143811A1 (es) |
| CL (1) | CL2022000087A1 (es) |
| GB (1) | GB2600599A (es) |
| IL (1) | IL289813A (es) |
| MX (1) | MX2022000603A (es) |
| TW (1) | TW202116801A (es) |
| WO (1) | WO2021010712A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201707855YA (en) | 2013-03-13 | 2017-10-30 | Prothena Biosciences Ltd | Tau immunotherapy |
| CA3022673A1 (en) | 2016-05-02 | 2017-11-09 | Prothena Biosciences Limited | Tau immunotherapy |
| EP3452508A1 (en) | 2016-05-02 | 2019-03-13 | Prothena Biosciences Limited | Antibodies recognizing tau |
| IL270375B1 (en) | 2017-05-02 | 2024-08-01 | Prothena Biosciences Ltd | Antibodies that recognize tau |
| TW202100550A (zh) | 2019-03-03 | 2021-01-01 | 愛爾蘭商普羅帝納生物科學公司 | 識別ｔａｕ之抗體 |
| WO2023039456A1 (en) * | 2021-09-09 | 2023-03-16 | The University Of North Carolina At Chapel Hill | Monoclonal antibodies targeting acetylated tau and methods of use thereof |
| WO2023041805A1 (en) | 2021-09-20 | 2023-03-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor |
| WO2023229445A1 (ko) * | 2022-05-27 | 2023-11-30 | 주식회사 진큐어 | 신규 펩타이드 및 그의 용도 |
| WO2024123052A1 (ko) * | 2022-12-08 | 2024-06-13 | 주식회사 아델 | 항-타우 항체 및 펩티드를 포함하는 융합체와 그의 용도 |
| WO2024133723A1 (en) | 2022-12-22 | 2024-06-27 | Institut National de la Santé et de la Recherche Médicale | Methods for decreasing therapeutic acquired resistance to chemotherapy and/or radiotherapy |
| CN116716352A (zh) * | 2023-05-16 | 2023-09-08 | 深圳湾实验室 | Tau蛋白聚集的细胞模型、其构建方法及应用 |
| CN116693682B (zh) * | 2023-06-02 | 2024-04-19 | 涌源合生科技(深圳)有限公司 | 抗Tau蛋白抗体及其制备方法和用途 |
| CN116948025B (zh) * | 2023-09-14 | 2024-04-02 | 北京凯祥弘康生物科技有限公司 | 一种抗Tau蛋白的抗体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130251731A1 (en) * | 2012-03-22 | 2013-09-26 | The Trustees Of The University Of Pennsylvania | Tau Acetylation in the Pathogenesis of Alzheimers Disease and Other Related Tauopathies |
| AU2013243861A1 (en) * | 2012-04-05 | 2014-10-23 | Ac Immune S.A. | Humanized Tau antibody |
| EP3838921A3 (en) * | 2012-07-03 | 2021-09-01 | Washington University | Antibodies to tau |
| TW202136296A (zh) * | 2014-06-27 | 2021-10-01 | 美商Ｃ２Ｎ醫療診斷有限責任公司 | 人類化抗-tau抗體 |
| TWI669314B (zh) * | 2015-02-26 | 2019-08-21 | 美國禮來大藥廠 | 針對ｔａｕ之抗體及其用途 |
| WO2018106889A1 (en) * | 2016-12-09 | 2018-06-14 | Cogwellin L.L.C. | Diagnosis of alzheimer's disease |
| WO2018117647A1 (ko) * | 2016-12-21 | 2018-06-28 | 주식회사 아델 | 변이된 타우 단백질 단편 및 이의 용도 |
-
2020
- 2020-07-13 WO PCT/KR2020/009207 patent/WO2021010712A1/ko unknown
- 2020-07-13 JP JP2022503414A patent/JP2022541539A/ja active Pending
- 2020-07-13 AU AU2020313751A patent/AU2020313751A1/en active Pending
- 2020-07-13 CA CA3143811A patent/CA3143811A1/en active Pending
- 2020-07-13 EP EP20841174.4A patent/EP4001305A4/en active Pending
- 2020-07-13 CN CN202080063893.8A patent/CN114430744B/zh active Active
- 2020-07-13 KR KR1020200086341A patent/KR102196840B1/ko active IP Right Grant
- 2020-07-13 GB GB2201160.5A patent/GB2600599A/en active Pending
- 2020-07-13 MX MX2022000603A patent/MX2022000603A/es unknown
- 2020-07-13 BR BR112022000719A patent/BR112022000719A2/pt unknown
- 2020-07-15 TW TW109123934A patent/TW202116801A/zh unknown
-
2022
- 2022-01-12 US US17/574,227 patent/US20220204601A1/en active Pending
- 2022-01-12 CL CL2022000087A patent/CL2022000087A1/es unknown
- 2022-01-12 IL IL289813A patent/IL289813A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7109467B2 (ja) | タウに特異的に結合する結合分子 | |
| JP2019527194A5 (es) | ||
| JP2018519810A5 (es) | ||
| AU2013211874B2 (en) | Humanized antibodies that recognize alpha-synuclein | |
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JPWO2021010712A5 (es) | ||
| JP2019528083A5 (es) | ||
| IL266911B1 (en) | Antibodies against tau and their uses in treating tauopathy, maintaining or increasing memory capacity or slowing memory loss | |
| NZ748983A (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
| JP2014502150A5 (es) | ||
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2018505651A5 (es) | ||
| WO2013039954A1 (en) | Anti-gitr antibodies | |
| KR20130051989A (ko) | 항―Ｎ３ｐＧｌｕ 아밀로이드 베타 펩티드 항체 및 그의 용도 | |
| JP2020529473A5 (es) | ||
| US10633435B2 (en) | Anti-PHF-tau antibodies and uses thereof | |
| AU2019377595A1 (en) | Antibodies recognizing tau | |
| JP2013508292A5 (es) | ||
| JP2017523805A5 (es) | ||
| US20220213188A1 (en) | Methods of treating neurodegenerative diseases | |
| CN116348487A (zh) | 抗淀粉样β抗体 | |
| JP2014502276A5 (es) | ||
| TW202309076A (zh) | 用於治療α-突觸核蛋白病之抗體 | |
| TW202300518A (zh) | 抗N3pGlu類澱粉β抗體及其用途 | |
| CA3119072A1 (en) | Antibodies recognizing tau |